BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7172473)

  • 1. Adrenoleukodystrophy: diagnosis and carrier detection by determination of long-chain fatty acids in cultured fibroblasts.
    Tönshoff B; Lehnert W; Ropers HH
    Clin Genet; 1982 Jul; 22(1):25-9. PubMed ID: 7172473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of female carriers of adrenoleukodystrophy.
    Moser HW; Moser AE; Trojak JE; Supplee SW
    J Pediatr; 1983 Jul; 103(1):54-9. PubMed ID: 6864396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First trimester prenatal diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe.
    Boué J; Oberle I; Heilig R; Mandel JL; Moser A; Moser H; Larsen JW; Dumez Y; Boué A
    Hum Genet; 1985; 69(3):272-4. PubMed ID: 3856557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.
    Watkins PA; Naidu S; Moser HW
    J Inherit Metab Dis; 1987; 10 Suppl 1():46-53. PubMed ID: 3119941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very long-chain fatty acids in erythrocyte membrane sphingomyelin: detection of ALD hemizygotes and heterozygotes.
    Tanaka K; Shimada M; Naruto T; Yamamoto H; Saeki Y; Sai H; Hirose G
    Neurology; 1986 Jun; 36(6):791-5. PubMed ID: 3703284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier detection for adrenoleukodystrophy by high-performance liquid chromatography.
    Sakai T; Antoku Y; Tsukamoto K; Imanishi K; Iwashita H; Gotoh I
    Exp Neurol; 1988 Jun; 100(3):556-62. PubMed ID: 3366206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
    Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
    Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.
    Moser HW; Moser AB; Frayer KK; Chen W; Schulman JD; O'Neill BP; Kishimoto Y
    Neurology; 1981 Oct; 31(10):1241-9. PubMed ID: 7202134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenoleukodystrophy.
    Lenard HG
    Neuropediatrics; 1984 Sep; 15 Suppl():16-9. PubMed ID: 6100794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.
    Christensen E; Grønn M; Hagve TA; Kase BF; Christophersen BO
    Biochim Biophys Acta; 1989 Mar; 1002(1):79-83. PubMed ID: 2538146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
    Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
    Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
    Moser HW; Moser AE; Singh I; O'Neill BP
    Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging compared with computed tomography in adrenoleukodystrophy.
    Huckman MS; Wong PW; Sullivan T; Zeller P; Geremia GK
    Am J Dis Child; 1986 Oct; 140(10):1001-3. PubMed ID: 3752010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
    Singh I; Moser AE; Moser HW; Kishimoto Y
    Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.
    Lazo O; Contreras M; Hashmi M; Stanley W; Irazu C; Singh I
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7647-51. PubMed ID: 3174658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenoleukodystrophy: clinical and biochemical manifestations in carriers.
    O'Neill BP; Moser HW; Saxena KM; Marmion LC
    Neurology; 1984 Jun; 34(6):798-801. PubMed ID: 6539445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoleukodystrophy.
    O'Neill BP; Moser HW
    Can J Neurol Sci; 1982 Nov; 9(4):449-52. PubMed ID: 6758925
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenoleukodystrophy: detection of increased very long chain fatty acids by high-performance liquid chromatography.
    Kobayashi T; Katayama M; Suzuki S; Tomoda H; Goto I; Kuroiwa Y
    J Neurol; 1983; 230(4):209-15. PubMed ID: 6198480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts.
    Sakai T; Antoku Y; Goto I; Ochiai J; Iwashita H; Kuroiwa Y; Katafuchi Y
    J Neurol Sci; 1985 Dec; 71(2-3):301-6. PubMed ID: 4087027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenoleukodystrophy mimicking multiple sclerosis.
    Dooley JM; Wright BA
    Can J Neurol Sci; 1985 Feb; 12(1):73-4. PubMed ID: 3978476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.